Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
ACE2‐Fc Potential treatment - pre-clinical evidence Experimental Antiviral Nov/06/2020 Nov/24/2020 0
2-(3-(3-Chloro-4-fluorobenzoyl)-7-fluoro-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide Potential treatment - theoretical effect Experimental Antiviral Nov/04/2020 Nov/24/2020 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020 Nov/24/2020 0
Polydatin Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 Nov/24/2020 0
Shufeng Jiedu Potential treatment - clinical evidence Natural product Other treatment Oct/22/2020 Nov/24/2020 0
Wogonin Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 Nov/24/2020 0